A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

• Status: Enrolling by invitation
• Trial end date: 2025-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital for Children and Adolescents, Finland
• Treatments: Estrogens; Estrone; Estropipate; Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Kallmann syndrome

• Age 15 yrs or more

Exclusion Criteria:

• Severe mental retardation